Forum Home | Log in | Signup | My Page | Rules | FAQ | Boards | Members | Search
« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: Results of a New Hydroxychloroquine Treatment Study on 1061 Patients 

By: Decomposed in POPE 5 | Recommend this post (2)
Mon, 13 Apr 20 5:31 PM | 42 view(s)
Boardmark this board | Pope 5 		Msg. 58744 of 62138
(This msg. is a reply to 58741 by hydro_gen)
Jump:
Jump to board:
Jump to msg. #

hydro_gen:

Re: "•A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%)."A problem I have with this report is that it doesn't discuss what outcomes would have been expected WITHOUT hydroxychloroquine. If you have 91% favorable results among patients who are at death's door, then that's awesome! But if it's 91% favorable results among patients selected at random, then the medication might not be doing anything at all. The article does nothing to clear that up.







Avatar

Gold is $1,581/oz today. When it hits $2,000, it will be up 26.5%. Let's see how long that takes. - De 3/11/2013 - ANSWER: 7 Years, 5 Months


 - - - - -
View Replies (2) »



» You can also:
- - - - -
The above is a reply to the following message:
Results of a New Hydroxychloroquine Treatment Study on 1061 Patients
By: hydro_gen in POPE 5
Mon, 13 Apr 20 5:20 PM 		Msg. 58741 of 62138

The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061 COVID-19 patients, treated for at least 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ) combination and a follow-up of at least 9 days was investigated.

Key findings are:

•No cardiac toxicity was observed.

•A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%).

A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization or more.

The authors conclude that:

“The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.”

http://www.paulcraigroberts.org/2020/04/11/professor-didier-raoult-releases-the-results-of-a-new-hydroxychloroquine-treatment-study-on-1061-patients/?fbclid=IwAR3vWDjlM1A6svXfxi3v44goylS5VFoTzfJZ0k9vGI5_YYI0iUyEN4Wpccs

« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next